Related Experiment Video
Updated: Jun 14, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Thrombosis and Thrombotic Risk in Athletes
Ciro Miele1,2,3, Cristina Mennitti1, Alessandro Gentile1
1Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Via Sergio Pansini 5, 80131 Napoli, Italy.
Physical activity can protect athletes, but exertion, dehydration, and immobilization increase venous thromboembolism (VTE) risk. New biomarkers and therapies are crucial for early diagnosis and athlete health.
Area of Science:
- Sports Medicine
- Hematology
- Physiology
Background:
- The hemostatic system balances pro- and anticoagulant forces; disruptions can lead to hemorrhage or thrombosis.
- Athletes face unique venous thromboembolism (VTE) risks from exertion, dehydration, immobilization, and certain sports.
- Current VTE biomarkers (e.g., D-dimer, Factor VIII) have complex interpretations and can indicate other conditions.
Purpose of the Study:
- To review the relationship between physical exercise and thromboembolism risk in athletes.
- To identify key factors contributing to thrombosis in professional athletes.
- To highlight the need for novel biomarkers and therapies for athlete health.
Main Methods:
- Literature review on exercise, hemostasis, and VTE in athletic populations.
- Analysis of factors contributing to deep vein thrombosis (DVT) in various sports.
- Discussion of current diagnostic markers and therapeutic strategies.
Main Results:
- Exercise offers protection, but specific factors like hemoconcentration and immobilization increase VTE risk.
- Certain sports involving repetitive motions or intense exertion are linked to upper and lower DVT.
- Existing biomarkers lack sufficient specificity for accurate VTE diagnosis in athletes.
Conclusions:
- Understanding the interplay between exercise and VTE is vital for athlete well-being.
- Development of sensitive and specific biomarkers is essential for early thromboembolism detection.
- Effective anticoagulant therapy remains critical for preventing serious complications like pulmonary embolism.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Clot Retraction and Fibrinolysis
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...

